Interferon-Beta Increases Plasma Ceramides of Specific Chain Length in Multiple Sclerosis Patients, Unlike Fingolimod or Natalizumab.
about
The Evaluation of Oxidative Stress Parameters in Serum Patients with Relapsing-Remitting Multiple Sclerosis Treated with II-Line Immunomodulatory Therapy.Preanalytical Biases in the Measurement of Human Blood Sphingolipids.Metabolic Dysfunction and Peroxisome Proliferator-Activated Receptors (PPAR) in Multiple Sclerosis.
P2860
Interferon-Beta Increases Plasma Ceramides of Specific Chain Length in Multiple Sclerosis Patients, Unlike Fingolimod or Natalizumab.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Interferon-Beta Increases Plas ...... ike Fingolimod or Natalizumab.
@en
Interferon-Beta Increases Plas ...... ike Fingolimod or Natalizumab.
@nl
type
label
Interferon-Beta Increases Plas ...... ike Fingolimod or Natalizumab.
@en
Interferon-Beta Increases Plas ...... ike Fingolimod or Natalizumab.
@nl
prefLabel
Interferon-Beta Increases Plas ...... ike Fingolimod or Natalizumab.
@en
Interferon-Beta Increases Plas ...... ike Fingolimod or Natalizumab.
@nl
P2093
P2860
P356
P1476
Interferon-Beta Increases Plas ...... like Fingolimod or Natalizumab
@en
P2093
Anja Schwiebs
Christoph A Mayer
Florian M Ottenlinger
Hanns Ackermann
Josef M Pfeilschifter
Katrin G Schmidt
Nerea Ferreirós
Yannick Schreiber
P2860
P356
10.3389/FPHAR.2016.00412
P577
2016-11-03T00:00:00Z